35.41
0.31%
+0.11
After Hours:
35.41
Tandem Diabetes Care Inc stock is currently priced at $35.41, with a 24-hour trading volume of 1.68M.
It has seen a +0.31% increased in the last 24 hours and a +33.22% rose in the past month.
The chart indicates a potential bullish trend, as the stock is above the $34.64 pivot point. If it approaches the $36.18 resistance level, significant changes may occur.
Tandem Diabetes Care Inc Stock (TNDM) Financials Data
Tandem Diabetes Care Inc (TNDM) Revenue 2023
TNDM reported a revenue (TTM) of $747.72 million for the quarter ending December 31, 2023, a -6.68% decline year-over-year.
Tandem Diabetes Care Inc (TNDM) Net Income 2023
TNDM net income (TTM) was -$222.61 million for the quarter ending December 31, 2023, a -135.33% decrease year-over-year.
Tandem Diabetes Care Inc (TNDM) Cash Flow 2023
TNDM recorded a free cash flow (TTM) of -$83.41 million for the quarter ending December 31, 2023, a -1,210% decrease year-over-year.
Tandem Diabetes Care Inc (TNDM) Earnings per Share 2023
TNDM earnings per share (TTM) was -$3.44 for the quarter ending December 31, 2023, a -132.43% decline year-over-year.
Tandem Diabetes Care Inc Stock (TNDM) Insider Trading
Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
---|---|---|---|---|---|---|---|
Carpenter Rick | Chief Technology Officer |
Mar 15 '24 |
Option Exercise |
0.00 |
405 |
0 |
6,245 |
Vosseller Leigh | EVP & CHIEF FINANCIAL OFFICER |
Feb 27 '24 |
Option Exercise |
0.00 |
407 |
0 |
13,082 |
Gasser Elizabeth Anne | EVP, Chief Strategy Officer |
Feb 27 '24 |
Option Exercise |
0.00 |
372 |
0 |
6,553 |
Sheridan John F | PRESIDENT & CEO |
Feb 27 '24 |
Option Exercise |
0.00 |
819 |
0 |
30,181 |
Morrison Susan | EVP & Chief Admin. Officer |
Feb 27 '24 |
Option Exercise |
0.00 |
407 |
0 |
15,564 |
Leal James | Chief Manufacturing Officer |
Feb 27 '24 |
Option Exercise |
0.00 |
309 |
0 |
10,941 |
Carpenter Rick | Chief Technology Officer |
Feb 15 '24 |
Option Exercise |
0.00 |
596 |
0 |
6,085 |
Morrison Susan | EVP & Chief Admin. Officer |
Feb 15 '24 |
Option Exercise |
0.00 |
638 |
0 |
15,319 |
Hansen Shannon Marie | Chief Legal Officer |
Feb 15 '24 |
Option Exercise |
0.00 |
531 |
0 |
3,794 |
Sheridan John F | PRESIDENT & CEO |
Feb 15 '24 |
Option Exercise |
0.00 |
3,029 |
0 |
30,279 |
Tandem Diabetes Care Inc Stock (TNDM) Latest News
Why Tandem Diabetes Care Stock Was Zooming Higher Today
The Motley Fool
Tesla, Krispy Kreme, McCormick And Other Big Stocks Moving Higher On Tuesday
Benzinga
Tandem Diabetes (TNDM) Gains From Innovation Amid Competition
Zacks Investment Research
Why Is Tandem Diabetes Care (TNDM) Up 27.4% Since Last Earnings Report?
Zacks Investment Research
Here's Why You Should Retain Tandem Diabetes (TNDM) Now
Zacks Investment Research
Tandem Diabetes Care, Inc. (TNDM) Surges 9.6%: Is This an Indication of Further Gains?
Zacks Investment Research
About Tandem Diabetes Care Inc
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States. The company's flagship product is the t:slim X2 insulin delivery system that comprises t:slim X2 pump, its 300-unit disposable insulin cartridge, and an infusion set. It also provides t:flex insulin delivery system that includes t:flex pump, its 480-unit disposable insulin cartridge, and an infusion set; t:slim X2 with G5 integration; and Tandem Device Updater, a PC and Mac-compatible tool that allows users to update their pump's software. In addition, the company offers t:connect diabetes management application, a cloud-based data management application, which provides a visual way to display therapy management data from the pump and supported blood glucose meters for users, their caregivers, and their healthcare providers; t:lock cartridge and infusion set products; and various pump accessories. Its products in development include automated insulin delivery systems; t:slim X2 with Basal IQ; t:slim X2 with control IQ; t:sport insulin delivery system; and connected (mobile) health mobile application. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was founded in 2006 and is headquartered in San Diego, California.
Cap:
|
Volume (24h):